← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2020Last known activity
May 20, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (21 distinct, 12 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (11 own, 0 via acquisition)
Recent trials (28)
- NCT07198919Sponsor investigatorPhase 1/Phase 2May 20, 2025
- NCT07198919Lead sponsorPhase 1/Phase 2May 20, 2025
- NCT06899672Sponsor investigatorN/AApr 1, 2025
- NCT06899672Lead sponsorN/AApr 1, 2025
- NCT06856239Sponsor investigatorN/AFeb 24, 2025
- NCT06856239Lead sponsorN/AFeb 24, 2025
- NCT06856239OfficialN/AFeb 24, 2025
- NCT06074952Study directorN/AOct 31, 2023
- NCT06074952Reponsible party - principal investigatorN/AOct 31, 2023
- NCT06074952Lead sponsorN/AOct 31, 2023
- NCT05744726Lead sponsorN/AJan 1, 2023
- NCT05744726Reponsible party - principal investigatorN/AJan 1, 2023
- NCT05306431Lead sponsorPhase 2Aug 1, 2022
- NCT05306431Reponsible party - principal investigatorPhase 2Aug 1, 2022
- NCT05568563Lead sponsorN/AAug 1, 2022
Details
- Last known activity
- May 20, 2025